Novo Nordisk CEO Lars Fruergaard Jørgensen will testify before Sen. Bernie Sanders' committee on the company's pricing of the popular diabetes drug Ozempic and the obesity drug Wegovy ...

(Reuters) -The Senate Committee on Health, Education, Labor, and Pensions said on Friday that Novo Nordisk CEO Lars Jorgensen has agreed to testify voluntarily in a hearing focusing on U.S. prices ...

The vote that was scheduled for next week was preempted with the announcement that Novo Nordisk CEO Lars Fruergaard Jørgensen had agreed to testify before the Senate Health, Education, Labor and ...

Norvo Nordisk (NVO) CEO agrees to testify before Senate on pricing strategy for weight loss drugs, Ozempic and Wegovy, avoiding subpoena. Read more here.

Bernie Sanders said the CEO of Novo Nordisk will testify on the cost of Ozempic and Wegovy. Lars Jørgensen will appear before the Senate Committee on Health, Education, Labor, and Pensions.

Sept. 24 (UPI) --The CEO of Novo Nordisk is on Capitol Hill Tuesday to testify before a Senate committee about the high costs of its drugs Ozempic and Wegovy.Chairman Sen. Bernie Sanders, I-Vt ...

Novo Nordisk is parting ways with its CEO Lars Fruergaard Jørgensen after the two parties mutually agreed that a change of leadership was required amid fierce glucagon-like peptide 1 receptor ...

Novo responded with a letter in May blaming the U.S. health system for the high prices, according to a report. Novo Nordisk CEO to testify in US Senate hearing on high cost of Ozempic, Wegovy View ...